A study assessing Daratumumab in patients with multiple myeloma undergoing autologous stem cell transplantation (ASCT)
Latest Information Update: 10 Jan 2021
At a glance
- Drugs Daratumumab (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 10 Jan 2021 New trial record
- 08 Dec 2020 Results presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology